NONOF Projected Dividend Yield
Cl B Ord/Novo-Nordisk AS ( OTCBB : NONOF )Novo Nordisk A/S is a global healthcare company engaged in diabetes care. Co. is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. Co. operates through two business segments: diabetes and obesity care, and biopharmaceuticals. Co.'s diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. Co.'s biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. Co. also offers Saxenda product to treat obesity. 21 YEAR PERFORMANCE RESULTS |
NONOF Dividend History Detail NONOF Dividend News NONOF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend Amount (DKK) |
2025 |
N/A |
N/A |
Mar 31, 2025 |
Apr 01, 2025 |
7.9000 |
2025 Total: |
7.9000 |
||||
2024 |
N/A |
N/A |
Aug 16, 2024 |
Aug 19, 2024 |
3.5000 |
2024 |
N/A |
N/A |
Mar 25, 2024 |
Mar 26, 2024 |
6.4000 |
2024 Total: |
9.9000 |
||||
2023 |
N/A |
N/A |
Aug 21, 2023 |
Aug 22, 2023 |
3.0000 |
2023 |
N/A |
N/A |
Mar 27, 2023 |
Mar 28, 2023 |
4.0750 |
2023 Total: |
7.0750 |
||||
2022 |
N/A |
N/A |
Aug 15, 2022 |
Aug 16, 2022 |
2.1250 |
2022 |
N/A |
N/A |
Mar 28, 2022 |
Mar 29, 2022 |
3.4500 |
2022 Total: |
5.5750 |
||||
2021 |
N/A |
N/A |
Aug 17, 2021 |
Aug 18, 2021 |
1.7500 |
2021 |
N/A |
N/A |
Mar 29, 2021 |
Mar 30, 2021 |
2.9250 |
2021 Total: |
4.6750 |
||||
2020 |
N/A |
N/A |
Aug 17, 2020 |
Aug 18, 2020 |
1.6250 |
2020 |
N/A |
N/A |
Mar 30, 2020 |
Mar 31, 2020 |
2.6750 |
2020 Total: |
4.3000 |